Jun 8 - 11, 2024
Metro Toronto Convention Centre, Toronto, Canada
SNMMI 2024
Society of Nuclear Medicine and Molecular Imaging
Join us at SNMMI 2024 in Toronto!
Discover our latest molecular imaging innovations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting in Toronto, Canada.
Visit us at booth 1339 to experience the launch of our new Biograph™ PET/CT, see how clinicians are using Biograph Vision Quadra™ total-body PET/CT to advance medicine, learn how Symbia Pro.specta™ sets new standards in SPECT/CT, hear the latest news from PETNET Solutions, Inc., discover how your theranostics program can benefit from a customized workflow solution, and find out how we enable the Alzheimer's disease care pathway to help you determine treatment with diagnostic confidence.
Toronto, Canada
Congress Information
Save the date for SNMMI 2024:
Date: June 8 - 11, 2024
Location: Toronto, Canada
Venue: Metro Toronto Convention Centre
(maps)
Symposia
The impact of precision PET/CT: today and opportunities for the future
Monday, June 10: 11:30 AM-12:30 PM (local time)
This two-part symposium will open with representatives from a US community imaging center sharing how the decision to modernize their imaging services with high-performance PET/CT is impacting clinical results and facilitating a more efficient and effective experience for patients and users.
A second session will focus on the emergence of new therapeutic strategies for Alzheimer’s disease and the clinical utility of PET/CT for diagnosis as well as the assessment of treatment efficacy.
Integrating theranostics to deliver personalized treatment in prostate cancer
Tuesday, June 11: 12:00-1:00 PM (local time)
Discover how two US theranostics programs are setting the standard in precision oncology with optimized molecular imaging protocols that enable effective and efficient cancer care without compromising patient comfort or high image quality.
PET/CT utilization for appropriate patient selection and follow-up to optimize patient outcomes
Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA
Quantitative SPECT/CT utilization for therapy response monitoring and dosimetry
Michael Morris, MD, founder and medical director, United Theranostics, Minneapolis, Minnesota, USA
Driving the future of PET/CT
Don't miss our on-demand videos
Product highlights
Learn more about our product highlights at SNMMI 2024.
xSPECT & FlowMotion 10-year anniversary
Join us in celebrating 10 years of game-changing innovation in molecular imaging with xSPECT™ and FlowMotion™.
PETNET Solutions, Inc.
See what's new from PETNET Solutions, Inc., a Siemens Healthineers company that operates the world's largest network of PET radiopharmacies, with 47 locations globally.
See our complete portfolio
Nuclear Medicine News & Stories
Your resource for the latest news, stories, and clinical cases in nuclear medicine and molecular imaging.
Are you interested?
Share
Do you find this page interesting? Share the information with peers.
We look forward to meeting you at SNMMI 2024 in Toronto, June 8-11, 2024.
The products/features mentioned herein are not commercially available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.